AU Patent

AU2023356620A1 — Crystal forms of an anti-sars cov-2 agent

Assigned to Enanta Pharmaceuticals Inc · Expires 2025-04-24 · 1y expired

What this patent protects

The present invention features crystalline forms of Compound I, including polymorphs and pseudopolymorphs, which are useful in the preparation of pharmaceutical compositions.

USPTO Abstract

The present invention features crystalline forms of Compound I, including polymorphs and pseudopolymorphs, which are useful in the preparation of pharmaceutical compositions.

Drugs covered by this patent

Patent Metadata

Patent number
AU2023356620A1
Jurisdiction
AU
Classification
—
Expires
2025-04-24
Drug substance claim
No
Drug product claim
No
Assignee
Enanta Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.